These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 23559101)
21. Current trends in pulp therapy: a survey analyzing pulpotomy techniques taught in pediatric dental residency programs. Walker LA; Sanders BJ; Jones JE; Williamson CA; Dean JA; Legan JJ; Maupome G J Dent Child (Chic); 2013; 80(1):31-5. PubMed ID: 23595242 [TBL] [Abstract][Full Text] [Related]
22. Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - part II: other clinical applications and complications. Torabinejad M; Parirokh M; Dummer PMH Int Endod J; 2018 Mar; 51(3):284-317. PubMed ID: 28846134 [TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of platelet-rich fibrin and mineral trioxide aggregate as pulpotomy agents in permanent teeth with incomplete root development: a randomized controlled trial. Keswani D; Pandey RK; Ansari A; Gupta S J Endod; 2014 May; 40(5):599-605. PubMed ID: 24767550 [TBL] [Abstract][Full Text] [Related]
24. Clinical and radiographic success rates of mineral trioxide aggregate and ferric sulphate pulpotomies performed by dental students. Odabaş ME; Alaçam A; Sillelioğlu H; Deveci C Eur J Paediatr Dent; 2012 Jun; 13(2):118-22. PubMed ID: 22762173 [TBL] [Abstract][Full Text] [Related]
25. Mineral trioxide aggregate: a comprehensive literature review--part II: leakage and biocompatibility investigations. Torabinejad M; Parirokh M J Endod; 2010 Feb; 36(2):190-202. PubMed ID: 20113774 [TBL] [Abstract][Full Text] [Related]
26. Comparison of bioactive glass, mineral trioxide aggregate, ferric sulfate, and formocresol as pulpotomy agents in rat molar. Salako N; Joseph B; Ritwik P; Salonen J; John P; Junaid TA Dent Traumatol; 2003 Dec; 19(6):314-20. PubMed ID: 15022999 [TBL] [Abstract][Full Text] [Related]
27. Treatment outcomes of pulpotomy in primary molars using two endodontic biomaterials. A 2-year randomised clinical trial. Malekafzali B; Shekarchi F; Asgary S Eur J Paediatr Dent; 2011 Sep; 12(3):189-93. PubMed ID: 22077689 [TBL] [Abstract][Full Text] [Related]
28. Randomized controlled trial of mineral trioxide aggregate and formocresol for pulpotomy in primary molar teeth. Aeinehchi M; Dadvand S; Fayazi S; Bayat-Movahed S Int Endod J; 2007 Apr; 40(4):261-7. PubMed ID: 17309744 [TBL] [Abstract][Full Text] [Related]
29. Healing process of dog dental pulp after pulpotomy and pulp covering with mineral trioxide aggregate or Portland cement. Holland R; de Souza V; Murata SS; Nery MJ; Bernabé PF; Otoboni Filho JA; Dezan Júnior E Braz Dent J; 2001; 12(2):109-13. PubMed ID: 11445912 [TBL] [Abstract][Full Text] [Related]
30. Understanding mineral trioxide aggregate/Portland-cement: a review of literature and background factors. Steffen R; van Waes H Eur Arch Paediatr Dent; 2009 Jun; 10(2):93-7. PubMed ID: 19627674 [TBL] [Abstract][Full Text] [Related]
31. The teaching of management of the pulp in primary molars in Europe: a preliminary investigation in Ireland and the UK. Ni Chaollai A; Monteiro J; Duggal MS Eur Arch Paediatr Dent; 2009 Jun; 10(2):98-103. PubMed ID: 19627675 [TBL] [Abstract][Full Text] [Related]
32. A randomized controlled study of the use of ProRoot mineral trioxide aggregate and Endocem as direct pulp capping materials. Song M; Kang M; Kim HC; Kim E J Endod; 2015 Jan; 41(1):11-5. PubMed ID: 25443279 [TBL] [Abstract][Full Text] [Related]
33. Human Pulp Responses to Partial Pulpotomy Treatment with TheraCal as Compared with Biodentine and ProRoot MTA: A Clinical Trial. Bakhtiar H; Nekoofar MH; Aminishakib P; Abedi F; Naghi Moosavi F; Esnaashari E; Azizi A; Esmailian S; Ellini MR; Mesgarzadeh V; Sezavar M; About I J Endod; 2017 Nov; 43(11):1786-1791. PubMed ID: 28822566 [TBL] [Abstract][Full Text] [Related]
34. Calcium hydroxide vs mineral trioxide aggregates for partial pulpotomy of permanent molars with deep caries. Qudeimat MA; Barrieshi-Nusair KM; Owais AI Eur Arch Paediatr Dent; 2007 Jun; 8(2):99-104. PubMed ID: 17555692 [TBL] [Abstract][Full Text] [Related]
35. A review of the literature on the efficacy of mineral trioxide aggregate in conservative dentistry. Hosoya N; Takigawa T; Horie T; Maeda H; Yamamoto Y; Momoi Y; Yamamoto K; Okiji T Dent Mater J; 2019 Oct; 38(5):693-700. PubMed ID: 31189792 [TBL] [Abstract][Full Text] [Related]
36. Mineral trioxide aggregate pulpotomies: a case series outcomes assessment. Witherspoon DE; Small JC; Harris GZ J Am Dent Assoc; 2006 May; 137(5):610-8. PubMed ID: 16739540 [TBL] [Abstract][Full Text] [Related]
37. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy. Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654 [TBL] [Abstract][Full Text] [Related]
38. Short communication: a pan-European comparison of the management of carious primary molar teeth by postgraduates in paediatric dentistry. Foley JI Eur Arch Paediatr Dent; 2012 Feb; 13(1):41-6. PubMed ID: 22293105 [TBL] [Abstract][Full Text] [Related]
39. Dental Pulp Response to RetroMTA after Partial Pulpotomy in Permanent Human Teeth. Bakhtiar H; Aminishakib P; Ellini MR; Mosavi F; Abedi F; Esmailian S; Esnaashari E; Nekoofar MH; Sezavar M; Mesgarzadeh V; About I J Endod; 2018 Nov; 44(11):1692-1696. PubMed ID: 30241682 [TBL] [Abstract][Full Text] [Related]
40. Pulp revascularization in immature permanent tooth with apical periodontitis using mineral trioxide aggregate. Saeki K; Fujita Y; Shiono Y; Morimoto Y; Maki K Case Rep Med; 2014; 2014():564908. PubMed ID: 24959181 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]